<?xml version="1.0" encoding="UTF-8"?>
<p>Serological assays are not routinely used for diagnosis of HCoV infections due to the lack of commercial reagents, let alone commercial reagents that have been vetted by clinical trials and the regulatory review process [
 <xref rid="CIT0040" ref-type="bibr">40</xref>,
 <xref rid="CIT0041" ref-type="bibr">41</xref>] (
 <xref rid="T0002" ref-type="table">Table 2</xref>). Serological assays, on the other hand, are important for understanding the epidemiology of emerging HCoVs, including the burden and role of asymptomatic infections.
</p>
